OBJECTIVE: The purpose of this article is to describe the feasibility and safety of a multidisciplinary approach to imaging-guided axillary staging that facilitates personalized, less invasive surgical management of the axilla through targeted axillary dissection in patients with biopsy-proven nodal metastasis undergoing neoadjuvant chemotherapy. CONCLUSION: Axillary nodal status, critical in breast cancer staging, affects prognosis and treatment. As the paradigm shifts toward minimally invasive therapy, a clip marker is placed in the biopsied metastatic node for patients with N1-N2 disease undergoing neoadjuvant chemotherapy to facilitate targeted axillary dissection of the clipped node. This node is typically localized with a radioactive seed at sentinel lymph node dissection to determine whether further axillary surgery is warranted.
OBJECTIVE: The purpose of this article is to describe the feasibility and safety of a multidisciplinary approach to imaging-guided axillary staging that facilitates personalized, less invasive surgical management of the axilla through targeted axillary dissection in patients with biopsy-proven nodal metastasis undergoing neoadjuvant chemotherapy. CONCLUSION: Axillary nodal status, critical in breast cancer staging, affects prognosis and treatment. As the paradigm shifts toward minimally invasive therapy, a clip marker is placed in the biopsied metastatic node for patients with N1-N2 disease undergoing neoadjuvant chemotherapy to facilitate targeted axillary dissection of the clipped node. This node is typically localized with a radioactive seed at sentinel lymph node dissection to determine whether further axillary surgery is warranted.
Authors: Clara Park; Frauke Chevalier; Volker Möbus; Petra Hoedl; Kerstin Engelmann; Stephan Falk; Doris Leithner; Benjamin Kaltenbach; Thomas J Vogl; Markus Müller-Schimpfle Journal: Breast Care (Basel) Date: 2020-02-21 Impact factor: 2.860
Authors: Seho Park; Ja Seung Koo; Gun Min Kim; Joohyuk Sohn; Seung Il Kim; Young Up Cho; Byeong-Woo Park; Vivian Youngjean Park; Jung Hyun Yoon; Hee Jung Moon; Min Jung Kim; Eun-Kyung Kim Journal: Cancer Res Treat Date: 2017-08-17 Impact factor: 4.679